Abstract
Topical agents have become a commonly used treatment modality in chronic pain management. The use of these agents continues to grow, largely due to the increasing variety of medications available for topical use and their limited side effect profile. This chapter will address some of the more commonly used topical agents.
Keywords
- Chronic pain
- Topical analgesics
- Compounded topical agents
- Diabetic peripheral neuropathy
- Post-herpetic neuralgia
- Complex regional pain syndrome
- Neuropathic pain
- Osteoarthritis
- Capsaicin
- Substance P
- Local anesthetic
- Lidocaine patch
- Nonsteroidal anti-inflammatory drug
- Methylsalicylate
- Diclofenac
- Doxepin
- Dimethyl sulfoxide
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- Ca++ :
-
Calcium
- CRPS:
-
Complex regional pain syndrome
- DMSO:
-
Dimethyl sulfoxide
- DPN:
-
Diabetic peripheral neuropathy
- EMLA:
-
Eutectic mixture of local anesthetics
- FDA:
-
Food & Drug Administration
- G6PD:
-
Glucose-6-phosphate dehydrogenase
- GABA:
-
Gamma amino butyric acid
- Na+ :
-
Sodium
- NMDA:
-
N-methyl d-aspartate
- NSAID:
-
Nonsteroidal anti-inflammatory drug
- PHN:
-
Post-herpetic neuralgia
- TCA:
-
Tricyclic antidepressant
- TRP:
-
Transient receptor potential
References
Argoff CE. Topical agents for the treatment of chronic pain. Curr Pain Headache Rep. 2006;10(1):11–9.
Theis JG, Koren G. Camphorated oil; still endangering the lives of Canadian children. CMAJ. 1995;152(11):1821–4.
Watson CPN. Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage. 1994;9:425–33.
Rains C, Bryson HM. Topical capsaicin: a review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy, and osteoarthritis. Drugs Aging. 1995;7:317–28.
Fuchs PN, Papagallo M, Meyer RA. Topical EMLA pre-treatment fails to decrease the pain induced by 1% topical capsaicin. Pain. 1999;80:637–42.
Yanigidate F, Strichartz GR. Local anesthetics. Handb Exp Pharmacol. 2007;177:95–127.
Hollman MW, Durieux ME. Local anesthetics and the inflammatory response. Anesthesiology. 2000;93:858–75.
Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol. 2003;43(2):111–7.
Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs-differences and similarities. N Engl J Med. 1991;324:1716–25.
http://nbcsports.msnbc.com/id/19144600/. Last accessed 2/5/2013.
Nair B, Taylor-Gjevre R. A review of topical diclofenac use in musculoskeletal disease. Pharmaceuticals. 2010;3:1892–908.
Kastrup EK, editor. Drug facts and comparisons. St. Louis: Wolters Kluwer Health; 2013. p. 3147–9.
McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol. 2000;49(6):574–9.
Gerner P, Mujtaba M, Sinnott CJ, Wang GK. Amitriptyline versus bupivacaine in rat sciatic nerve blockade. Anesthesiology. 2001;94:661–7.
Khan MA, Gerner P, Wang GK. Amitriptyline for prolonged cutaneous analgesia in the rat. Anesthesiology. 2002;96:109–16.
Long TD, Cathers TA, Twillman R, O’Donnell T, Garrigues N. Morphine-infused silver sulfadiazine cream for burn analgesia: a pilot study. J Burn Care Rehabil. 2001;22:118–23.
Cerchietti LC, Navigante AH, Bonomi MR, Zaderajko MA, Menendez PR, Pogany CE, Roth BM. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer. 2002;95(10):2230–6.
Watterson G, Howard R, Goldman A. Peripheral opiates in inflammatory pain. Arch Dis Child. 2004;89:679–81.
Capriotti K, Capriotti JA. Dimethyl sulfoxide: history chemistry, and clinical utility in dermatology. J Clin Aesthet Dermatol. 2012;5(9):24–6.
Meyer T, Martin E, Prielipp R. The largest healthcare associated fungal outbreak in the U.S. APSF Newslett. 2013;28(1):4–7.
Ness TJ, Jones L, Smith H. Use of compounded topical analgesics-results of an internet survey. Reg Anesth Pain Med. 2002;27:309–12.
Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden 3rd JD, Kugler JW, Hoff KL, Reddy PS, Rowland Jr KM, Riepl M, Christensen B, Loprinzi CL. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011;19(6):833–41.
Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology. 2005;103(1):140–6.
Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain. 2005;6(10):644–9.
Quan D, Wellish M, Gilden DH. Topical ketamine treatment of post-herpetic neuralgia. Neurology. 2003;60:1391–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
McAllister, R.K., Burnett, C.J. (2015). Topical Analgesic Medications. In: Sackheim, K. (eds) Pain Management and Palliative Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2462-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2462-2_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2461-5
Online ISBN: 978-1-4939-2462-2
eBook Packages: MedicineMedicine (R0)